Basics United Therapeutics Corporation United Therapeutics Corp is engaged in the healthcare sector. Its core offering includes pharmaceutical products to address unmet medical needs of patients. IPO Date: June 17, 1999 Sector: Healthcare Industry: Biotech Market Cap: $14.68B Activated in VL: True Average Daily Range Avg Daily Range: $1.58 | 1.39% Avg Daily Range (30 D): $3.97 | 1.29% Avg Daily Range (90 D): $5.06 | 1.59% Institutional Daily Volume Avg Daily Volume: .52M Avg Daily Volume (30 D): .35M Avg Daily Volume (90 D): .36M Trade Size Avg Trade Size (Sh.): 91 Avg Trade Size (Sh.) (30 D): 29 Avg Trade Size (Sh.) (90 D): 30 Institutional Trades Total Inst.Trades: 14,173 Avg Inst. Trade: $4.57M Avg Inst. Trade (30 D): $16.75M Avg Inst. Trade (90 D): $18.56M Avg Inst. Trade Volume: .05M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $8.7M Avg Closing Trade (30 D): $21.94M Avg Closing Trade (90 D): $25.34M Avg Closing Volume: 57.41K     News May 23, 2025 @ 6:28 PM U.S. FDA Approves Liquidia’s YUTREPIAâ„Â... Source: Liquidia Corporation May 12, 2025 @ 10:00 AM Liquidia Corporation Provides Update on Litigation... Source: N/A May 2, 2025 @ 9:28 PM District Court Dismisses Dispute Filed by United T... Source: Liquidia Corporation Mar 20, 2025 @ 2:00 PM Market Turbulence? These 20 Stocks Boast a Perfect... Source: David Wagner Mar 20, 2025 @ 11:10 AM Market Turbulence? These 20 Stocks Boast a Perfect... Source: David Wagner Financials   TTM Q1 2025 Q4 2024 Basic EPS $27.08 $7.18 $6.71 Diluted EPS $25.08 $6.63 $6.21 Revenue $ 2.99B $ 794.4M $ 735.9M Gross Profit $ 2.66B $ 701.9M $ 660M Net Income / Loss $ 1.21B $ 322.2M $ 301.3M Operating Income / Loss $ 1.4B $ 382.8M $ 357.7M Cost of Revenue $ 329.3M $ 92.5M $ 75.9M Net Cash Flow $ 648.4M $ 202.7M $ 143.3M PE Ratio 0.00     Splits Sep 23, 2009:   2:1